Learn more about Peter Attia’s digital program
#185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we assess risk
“If we’re still saying the same things we said 30 years ago, it could be a problem because we should have learned how to say it better, more accurately.” —Allan Sniderman
Does fish oil cause cardiac arrhythmia in high-risk individuals?
Reports of increased risk of atrial fibrillation in high-risk patients taking fish oil
#181 – Robert Gatenby, M.D.: Viewing cancer through an evolutionary lens and why this offers a radically different approach to treatment
“For a century we’ve been looking for magic bullets, but maybe all we need is a series of pretty good bullets.” —Bob Gatenby
#180 – AMA #28: All things testosterone and testosterone replacement therapy
“There were countless other studies to look at, but they all basically point in the same direction, which is testosterone replacement therapy improves lean mass, reduces fat mass, improves strength.” —Peter Attia
#178 – Lance Armstrong: The rise, fall, and growth of a cycling legend
“That guy needed to die and a new guy needed to come around.” —Lance Armstrong
#177 – Steven Rosenberg, M.D., Ph.D.: The development of cancer immunotherapy and its promise for treating advanced cancers
“It’s the balance of the aggressive immune reaction against the inhibitory molecules that can prevent that immune reaction that is the holy grail of trying to find effective treatments.” —Steven Rosenberg
Does low cholesterol cause cognitive impairment? Part II
Safety of lipid-lowering therapy
Does low cholesterol cause cognitive impairment? Part I
Safety of lipid-lowering therapy
#173 – AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions
“Zone two is a metabolic state. It’s not determined by speed. It’s determined by which energy system you’re requiring and what the equilibrium is.” —Peter Attia
#170 – AMA #25: Navigating the complexities and nuances of cancer screening
“We screen often, we screen early, and we screen aggressively.” —Peter Attia